These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 14198741)

  • 1. LAEVADOSIN FOR MUSCULAR DYSTROPHY.
    THOMSON WH
    Br Med J; 1964 Oct; 2(5417):1135-6. PubMed ID: 14198741
    [No Abstract]   [Full Text] [Related]  

  • 2. A trial of therapy by nucleosides and nucleotides in muscular dystrophy.
    THOMSON WH; GUEST KE
    J Neurol Neurosurg Psychiatry; 1963 Apr; 26(2):111-22. PubMed ID: 13981251
    [No Abstract]   [Full Text] [Related]  

  • 3. LAEVADOSIN IN TREATMENT OF DUCHENNE TYPE OF MUSCULAR DYSTROPHY: PRELIMINARY RESULTS OF A DOUBLE-BLIND CONTROLLED TRIAL.
    PEARCE JM; GUBBAY SS; HARDY J; PENNINGTON RJ; NEWELL DJ; WALTON JN
    Br Med J; 1964 Oct; 2(5414):915-7. PubMed ID: 14185658
    [No Abstract]   [Full Text] [Related]  

  • 4. [New aspects of the management of progressive muscular dystrophy].
    Tilscher H; Schenk S
    Wien Med Wochenschr; 1967 Nov; 117(44):1000-2. PubMed ID: 5591872
    [No Abstract]   [Full Text] [Related]  

  • 5. LAEVADOSIN IN MUSCULAR DYSTROPHY.
    JACOBS J
    Br Med J; 1965 Sep; 2(5463):704. PubMed ID: 14337743
    [No Abstract]   [Full Text] [Related]  

  • 6. The significance of the dilution effect in serum creatine kinase diagnosis of muscular dystrophy.
    Spikesman AM; Brock DJ
    Clin Chim Acta; 1969 Dec; 26(3):387-9. PubMed ID: 5358538
    [No Abstract]   [Full Text] [Related]  

  • 7. LAEVADOSIN IN MUSCULAR DYSTROPHY.
    WALTON JN; GUBBAY SS; HUDGSON P; NEWELL DJ
    Br Med J; 1965 Aug; 2(5460):533. PubMed ID: 14321233
    [No Abstract]   [Full Text] [Related]  

  • 8. Serum ATP: creatine phosphotransferase in skeleto-muscular disorders with special reference to duchenne muscular dystrophy.
    Griffiths PD
    Guys Hosp Rep; 1965; 114(4):401-20. PubMed ID: 5859368
    [No Abstract]   [Full Text] [Related]  

  • 9. COMPOUNDS OF FERRIC IRON WITH ADENOSINE TRIPHOSPHATE AND OTHER NUCLEOSIDE PHOSPHATES. REP 591.
    GOUCHER CR
    Rep US Army Med Res Lab; 1963 Oct; ():1-21. PubMed ID: 14133523
    [No Abstract]   [Full Text] [Related]  

  • 10. LAEVADOSIN IN MUSCULAR DYSTROPHY.
    THOMSON WH
    Br Med J; 1965 Sep; 2(5462):647. PubMed ID: 14331636
    [No Abstract]   [Full Text] [Related]  

  • 11. GLYCOGEN, CREATINE, AND HIGH ENERGY PHOSPHATE IN HUMAN MUSCLE DISEASE.
    VIGNOS PJ; WARNER JL
    J Lab Clin Med; 1963 Oct; 62():579-90. PubMed ID: 14080857
    [No Abstract]   [Full Text] [Related]  

  • 12. [Therapeutic possibilities in progressive muscular dystrophy].
    Beckmann R; von Osten V
    Dtsch Med Wochenschr; 1966 Jan; 91(3):108-16. PubMed ID: 5901816
    [No Abstract]   [Full Text] [Related]  

  • 13. The reaction of nucleotide substrate analogues with denosine triphosphate-creatine phosphotransferase.
    James E; Morrison JF
    J Biol Chem; 1966 Oct; 241(20):4758-70. PubMed ID: 5926181
    [No Abstract]   [Full Text] [Related]  

  • 14. [The treatment of progressive muscular dystrophy with nucleosides and nucleotides. Clinical and serologic findings (aldolase and creatinphosphokinase)].
    Ceccarelli A; Leone P; Moretti A
    Clin Pediatr (Bologna); 1967 Sep; 49(9):468-75. PubMed ID: 5608288
    [No Abstract]   [Full Text] [Related]  

  • 15. Treatment of muscular dystrophy with "Laevadosin".
    Lip P; Flanagan J; Murray P
    Med J Aust; 1969 Jun; 1(26):1386. PubMed ID: 5797171
    [No Abstract]   [Full Text] [Related]  

  • 16. WATER CONTENT OF PAPER AS A VARIABLE IN PAPER CHROMATOGRAPHY.
    TOMISEK AJ; ALLAN PW
    J Chromatogr; 1964 Apr; 14():232-7. PubMed ID: 14165959
    [No Abstract]   [Full Text] [Related]  

  • 17. [Clinical studies and attempted ATP therapy of progressive muscular dystrophy in children].
    KOBIELOWA Z; MARKOWA M
    Neurol Neurochir Psychiatr Pol; 1961; 11():803-9. PubMed ID: 14457505
    [No Abstract]   [Full Text] [Related]  

  • 18. Cooperative effects of substrates and substrate analogs on the conformation of creatine phosphokinase.
    Lui NS; Cunningham L
    Biochemistry; 1966 Jan; 5(1):144-9. PubMed ID: 5938932
    [No Abstract]   [Full Text] [Related]  

  • 19. [ON THE DETERMINATION OF MYOKINASE (ADENYLATE KINASE) ACTIVITY IN THE SERUM].
    SCHMIDT FH
    Klin Wochenschr; 1964 May; 42():476-8. PubMed ID: 14231203
    [No Abstract]   [Full Text] [Related]  

  • 20. Studies on progressive muscular dystrophy. 3. Breakdown of adenosine nucleotides in human blood.
    Nakahara M
    Arzneimittelforschung; 1965 Aug; 15(8):932-4. PubMed ID: 5898654
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.